MannKind

MNKD · NASDAQ

$3.10+$0.01 (+0.32%)TodayMarket closed · Oct 20, 7:53 PM ET

Prev close $3.09

Latest news

NewsSep 9, 11:34 AM ETVandana Singh
Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule
Press releaseSep 9, 6:30 AM ETGlobe Newswire
MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
NewsAug 5, 4:02 PM ET
MannKind Q2 Adj. EPS $(0.01) Misses $(0.00) Estimate, Sales $109.374M Beat $108.915M Estimate
Press releaseAug 5, 4:01 PM ETGlobe Newswire
MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update
NewsJul 24, 2:06 PM ETVandana Singh
FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease
Press releaseJul 24, 6:35 AM ETGlobe Newswire
MannKind Announces $50 Million Private Placement
NewsJun 5, 8:05 AM ETAvi Kapoor
Jim Cramer Puts This Chip Stock In The 'Penalty Box,' Warns Occidental Could 'Go Down A Lot' If War Ends
Press releaseMay 27, 9:05 AM ETGlobe Newswire
MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems
Press releaseMay 12, 10:30 AM ETPRNewswire
The $59B Quiet Shift Reshaping How Patients Access Care
NewsMay 7, 8:04 AM ETAvi Kapoor
Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
NewsMay 6, 5:03 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
NewsMay 6, 4:08 PM ET
MannKind Q1 Adj. EPS $(0.02) Misses $(0.00) Estimate, Sales $90.171M Miss $106.555M Estimate
Press releaseMay 6, 4:01 PM ETGlobe Newswire
MannKind Reports First Quarter 2026 Financial Results and Provides Business Update
NewsMay 6, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsMay 6, 8:06 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsMay 6, 6:35 AM ET
MannKind Develops Dry Powder Inhalation Formulation Of Ralinepag, Known As Ralinepag DPI, For United Therapeutics
Press releaseMay 6, 6:30 AM ETGlobe Newswire
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
Press releaseMar 18, 10:00 AM ETPRNewswire
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
Press releaseMar 9, 9:05 AM ETGlobe Newswire
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
NewsFeb 27, 12:30 PM ETNabaparna Bhattacharya
What's Going On With MannKind Stock Friday?
NewsFeb 25, 12:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseJan 29, 1:31 PM ETPRNewswire
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration
Press releaseJan 26, 10:16 AM ETPRNewswire
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
Press releaseJan 23, 12:56 PM ETGlobe Newswire
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
Press releaseJan 8, 8:05 AM ETGlobe Newswire
MannKind Provides Business Updates and 2026 Growth Drivers
Press releaseSep 16, 12:17 PM ETBusiness Wire
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH
Press releaseAug 26, 5:58 PM ETBusiness Wire
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH
NewsAug 25, 1:57 PM ETVandana Singh
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
NewsAug 5, 3:03 PM ET
A Look Ahead: MannKind's Earnings Forecast
NewsMay 8, 4:33 AM ET
Earnings Scheduled For May 8, 2025
NewsMay 7, 5:01 PM ET
MannKind's Earnings Outlook
NewsDec 16, 4:02 PM ETVaishali Prayag
MannKind Shares Are falling Today: What's Going On?
NewsAug 28, 10:17 AM ETAvi Kapoor
Kohl's Posts Upbeat Q2 Earnings, Joins Box, Waldencast, AeroVironment And Other Big Stocks Moving Higher On Wednesday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

MannKind Q2 Adj. EPS $(0.01) Misses $(0.00) Estimate, Sales $109.374M Beat $108.915M Estimate

MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

MannKind Announces $50 Million Private Placement

Jim Cramer Puts This Chip Stock In The 'Penalty Box,' Warns Occidental Could 'Go Down A Lot' If War Ends

MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems

The $59B Quiet Shift Reshaping How Patients Access Care

Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Scheduled For May 6, 2026

MannKind Q1 Adj. EPS $(0.02) Misses $(0.00) Estimate, Sales $90.171M Miss $106.555M Estimate

MannKind Reports First Quarter 2026 Financial Results and Provides Business Update

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

MannKind Develops Dry Powder Inhalation Formulation Of Ralinepag, Known As Ralinepag DPI, For United Therapeutics

MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases

A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.

MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026

What's Going On With MannKind Stock Friday?

12 Health Care Stocks Moving In Wednesday's Intraday Session

Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration

Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets

Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets

MannKind Provides Business Updates and 2026 Growth Drivers

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal

A Look Ahead: MannKind's Earnings Forecast

Earnings Scheduled For May 8, 2025

MannKind's Earnings Outlook

MannKind Shares Are falling Today: What's Going On?

Kohl's Posts Upbeat Q2 Earnings, Joins Box, Waldencast, AeroVironment And Other Big Stocks Moving Higher On Wednesday